Surmodics ROE 2010-2025 | SRDX
Current and historical return on equity (ROE) values for Surmodics (SRDX) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Surmodics ROE - Return on Equity Historical Data |
| Date |
TTM Net Income |
Shareholder's Equity |
Return on Equity |
| 2025-03-31 |
$-0.02B |
$0.11B |
-17.43% |
| 2024-12-31 |
$-0.02B |
$0.11B |
-12.68% |
| 2024-09-30 |
$-0.01B |
$0.12B |
-9.94% |
| 2024-06-30 |
$0.00B |
$0.12B |
-1.65% |
| 2024-03-31 |
$0.01B |
$0.12B |
10.88% |
| 2023-12-31 |
$0.01B |
$0.12B |
4.38% |
| 2023-09-30 |
$0.00B |
$0.12B |
-1.81% |
| 2023-06-30 |
$-0.02B |
$0.11B |
-22.33% |
| 2023-03-31 |
$-0.04B |
$0.10B |
-33.41% |
| 2022-12-31 |
$-0.03B |
$0.11B |
-27.91% |
| 2022-09-30 |
$-0.03B |
$0.11B |
-22.27% |
| 2022-06-30 |
$-0.01B |
$0.13B |
-9.72% |
| 2022-03-31 |
$-0.01B |
$0.13B |
-7.26% |
| 2021-12-31 |
$0.00B |
$0.14B |
1.43% |
| 2021-09-30 |
$0.01B |
$0.14B |
3.60% |
| 2021-06-30 |
$0.00B |
$0.14B |
1.46% |
| 2021-03-31 |
$0.01B |
$0.14B |
5.21% |
| 2020-12-31 |
$0.00B |
$0.13B |
0.00% |
| 2020-09-30 |
$0.00B |
$0.13B |
0.00% |
| 2020-06-30 |
$0.01B |
$0.13B |
5.58% |
| 2020-03-31 |
$0.01B |
$0.13B |
4.90% |
| 2019-12-31 |
$0.01B |
$0.12B |
5.00% |
| 2019-09-30 |
$0.01B |
$0.12B |
5.94% |
| 2019-06-30 |
$0.00B |
$0.12B |
0.88% |
| 2019-03-31 |
$0.00B |
$0.12B |
-2.68% |
| 2018-12-31 |
$0.00B |
$0.11B |
-1.80% |
| 2018-09-30 |
$-0.01B |
$0.11B |
-4.52% |
| 2018-06-30 |
$0.00B |
$0.11B |
-2.70% |
| 2018-03-31 |
$0.00B |
$0.11B |
0.90% |
| 2017-12-31 |
$0.00B |
$0.11B |
0.00% |
| 2017-09-30 |
$0.00B |
$0.11B |
3.66% |
| 2017-06-30 |
$0.01B |
$0.11B |
6.48% |
| 2017-03-31 |
$0.01B |
$0.11B |
9.39% |
| 2016-12-31 |
$0.01B |
$0.11B |
9.62% |
| 2016-09-30 |
$0.01B |
$0.11B |
10.89% |
| 2016-06-30 |
$0.01B |
$0.10B |
9.25% |
| 2016-03-31 |
$0.01B |
$0.10B |
9.57% |
| 2015-12-31 |
$0.01B |
$0.10B |
12.15% |
| 2015-09-30 |
$0.01B |
$0.09B |
13.75% |
| 2015-06-30 |
$0.01B |
$0.09B |
14.61% |
| 2015-03-31 |
$0.01B |
$0.09B |
14.40% |
| 2014-12-31 |
$0.01B |
$0.08B |
13.08% |
| 2014-09-30 |
$0.01B |
$0.10B |
12.83% |
| 2014-06-30 |
$0.01B |
$0.10B |
15.18% |
| 2014-03-31 |
$0.01B |
$0.09B |
13.98% |
| 2013-12-31 |
$0.02B |
$0.09B |
15.67% |
| 2013-09-30 |
$0.02B |
$0.09B |
15.27% |
| 2013-06-30 |
$0.01B |
$0.10B |
14.21% |
| 2013-03-31 |
$0.01B |
$0.10B |
12.56% |
| 2012-12-31 |
$0.01B |
$0.10B |
9.80% |
| 2012-09-30 |
$0.01B |
$0.10B |
8.24% |
| 2012-06-30 |
$-0.01B |
$0.15B |
-7.60% |
| 2012-03-31 |
$-0.01B |
$0.15B |
-6.81% |
| 2011-12-31 |
$-0.01B |
$0.14B |
-6.73% |
| 2011-09-30 |
$-0.02B |
$0.14B |
-12.54% |
| 2011-06-30 |
$-0.02B |
$0.16B |
-14.19% |
| 2011-03-31 |
$-0.03B |
$0.15B |
-16.95% |
| 2010-12-31 |
$-0.03B |
$0.16B |
-17.60% |
| 2010-09-30 |
$-0.02B |
$0.15B |
-12.37% |
| 2010-06-30 |
$0.00B |
$0.18B |
2.30% |
| 2010-03-31 |
$0.01B |
$0.18B |
5.22% |
| 2009-12-31 |
$0.01B |
$0.18B |
7.68% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.395B |
$0.126B |
|
Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings.
|
